A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

Belantamab Bortezomib Dexamethasone Weekly

Description
Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen • Belantamab Mafodotin – Bortezomib - Dex
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf

Epilepsy: information for parents and guardians - patient information

Description
This factsheet explains what epilepsy is and how you can live well with epilepsy.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Epilepsy-information-for-parents-and-guardians-2177-PIL.pdf

Glasses for children - patient information

Description
This factsheet contains information about your child's glasses test appointment.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Glasses-for-children-1775-PIL.pdf

Having a peripherally inserted central catheter (PICC) insertion - patient information

Description
This factsheet explains what a peripherally inserted central catheter (PICC) is and what the procedure to insert a PICC involves.
Url
/Media/UHS-website-2019/Patientinformation/Scansandx-rays/Having-a-peripherally-inserted-central-catheter-PICC-insertion-1922-PIL.pdf

Having a myelogram - patient information

Description
This factsheet explains what a myelogram is, what the procedure involves and how to prepare for it.
Url
/Media/UHS-website-2019/Patientinformation/Scansandx-rays/Having-a-myelogram-2064-PIL.pdf

Your baby's home oxygen therapy - patient information

Description
This factsheet explains what home oxygen therapy is and what it involves, so you know what to expect when your baby goes home from hospital.
Url
/Media/UHS-website-2019/Patientinformation/Neonatal/Your-babys-home-oxygen-therapy-3883-PIL.pdf

People and OD Committee ToR September 2025

Description
People and Organisational Development Committee Terms of Reference Date Issued: 9 September 2025 Review Date: August 2026 Document Type: Committee Terms of Reference Version: 7 Contents Paragraph 1 2 3 4 5 6 7 8 9 10 Role and Purpose Constitution Membership Attendance and Quorum Frequency of Meetings Conduct and Administration of Meetings Duties and Responsibilities Accountability and Reporting Review of Terms of Reference and Performance and Effectiveness References Appendices Appendix A Committee and Reporting Structure Page 2 2 2 3 3 3 4 5 5 6 Page 7 Document Status This is a controlled document. Whilst this document may be printed, the electronic version posted on the intranet is the controlled copy. Any printed copies of this document are not controlled. As a controlled document, this document should not be saved onto local or network drives but should always be accessed from the intranet. Page 1 of 8 1. Role and Purpose 1.1 The People and Organisational Development Committee (the Committee) is responsible for overseeing, monitoring and reviewing the development and implementation of the people and organisational development strategies and operational plans for University Hospital Southampton NHS Foundation Trust (UHS or the Trust), including the three areas of culture, capacity and capability and skills and the Trust’s response to specific workforce issues arising from the coronavirus pandemic and the recovery of the organisation. 1.2 The Committee provides the board of directors of the Trust (the Board) with a means of assurance regarding the Trust’s culture, capacity and capability and skills in support of the provision of world-class care for all. 2. Constitution 2.1 The Committee has been established by the Board. The Committee has no executive powers other than those set out in these terms of reference. It is supported in its work by other committees established by the Board and other committees and groups as shown in Appendix A. 2.2 The Committee is authorised by the Board to investigate any activity within its terms of reference. It is authorised to seek any information it requires from any member of staff and all members of staff are directed to cooperate with any request made by the Committee. 2.3 In carrying out its role the Committee is authorised to seek reports and assurance from executive directors and managers and will maintain effective relationships with the chairs of other Board committees to understand their processes of assurance and links with the work of the Committee. 2.4 The Committee is authorised to obtain external legal or other independent professional advice if it considers this necessary, taking into consideration any issues of confidentiality and the Trust’s standing financial instructions. 3. Membership 3.1 The members of the Committee will be appointed by the Board and will be: 3.1.1 at least two non-executive directors of the Trust; 3.1.2 the Chief Executive; 3.1.3 the Chief Nursing Officer; 3.1.4 the Chief Medical Officer; and 3.1.5 the Chief People Officer. 3.2 The Board will appoint the chair of the Committee from among its non-executive director members (the Committee Chair). In the absence of the Committee Chair and/or an appointed deputy, the remaining members present will elect one of the non-executive director members present to chair the meeting. 3.3 Other individuals may be invited for one of more topics to be present depending on the nature of the agenda item. 3.4 Governors may be invited to attend meetings of the Committee. Page 2 of 8 4. Attendance and Quorum 4.1 Members should aim to attend every meeting and should attend a minimum of two- thirds of meetings held in each financial year. Where a member is unable to attend a meeting they should notify the Committee Chair or secretary in advance. 4.2 The quorum for a meeting will be three members, including two non-executive directors and either the Chief People Officer or the Chief Nursing Officer. A duly convened meeting of the Committee at which a quorum is present will be competent to exercise all or any of the authorities, powers and discretions vested in or exercisable by the Committee. 4.3 When an executive director or manager is unable to attend a meeting they should appoint a deputy to attend on their behalf. A deputy for an executive director will not count towards quoracy. 5. Frequency of Meetings 5.1 The Committee will meet at least six times each year and otherwise as required. 6. Conduct and Administration of Meetings 6.1 Meetings of the Committee will be convened by the secretary of the Committee at the request of the Committee Chair or any of its members. 6.2 The agenda of items to be discussed at the meeting will be agreed by the Committee Chair with support from the Chief People Officer. The agenda and supporting papers will be distributed to each member of the Committee and the regular attendees no later than four working days before the date of the meeting. Distribution of any papers after this deadline will require the agreement of the Committee Chair. 6.3 The secretary of the Committee will minute the proceedings of all meetings of the Committee, including recording the names of those present and in attendance and any declarations of interest. 6.4 Draft minutes of Committee meetings and a separate record of the actions to be taken forward will be circulated promptly to all members of the Committee. Once approved by the Committee, minutes will be circulated to all other members of the Board unless it would be inappropriate to do so in the opinion of the Committee Chair. 7. Duties and Responsibilities The Committee will carry out the duties below for the Trust whilst making reference to the People Strategy and in particular the three pillars of Thrive, Excel and Belong 7.1 Culture 7.1.1 The Committee will ensure that there are robust policies, systems and procedures for the development and monitoring of an inclusive culture with the Trust. 7.1.2 The Committee may review and monitor the following ensuring these support the achievement of the Trust People Strategy and Trust’s objectives. It will identify areas for action at a corporate and local level, ensuring follow up takes place: 7.1.2.1 staff and team engagement; 7.1.2.2 compassionate and inclusive leadership; 7.1.2.3 quality improvement; 7.1.2.4 equality, diversity and inclusivity; 7.1.2.5 bullying and harassment; Page 3 of 8 7.1.2.6 staff sickness and wellbeing 7.1.2.7 Freedom to Speak Up and raising concerns; 7.1.2.8 people aspects of the corporate and clinical strategy; and 7.2 Capacity 7.2.1 The Committee will ensure that there are robust policies, systems and procedures to ensure delivery and monitoring of workforce planning and recruitment and retention of staff. 7.2.2 The Committee may review and monitor the following ensuring these support the achievement of the Trust People Strategy and Trust’s objectives. It will identify areas for action at a corporate and local level, ensuring follow up takes place: 7.2.2.1 strategic workforce planning; 7.2.2.2 recruitment and retention; 7.2.2.3 staffing levels; 7.2.2.4 reports from the Guardian of Safe Working Hours; 7.2.2.5 talent management; 7.2.2.6 reward including pensions; 7.2.2.7 CQUINs; 7.2.2.8 bank and agency staff; and 7.2.2.9 volunteers. 7.3 Capability and Skills 7.3.1 The Committee will ensure that there are robust policies, systems and procedures to ensure delivery and monitoring of staff appraisal and development. 7.3.2 The Committee will review and monitor the following ensuring these support the achievement of the Trust People Strategy and Trust’s objectives. It willidentify areas for action at a corporate and local level, ensuring follow up takes place: 7.3.2.1 appraisals; 7.3.2.2 education and training; 7.3.2.3 mandatory training; 7.3.2.4 gaps to meet the long-term corporate and clinical strategy; 7.3.2.5 the annual staff survey; 7.3.2.6 the ‘fit and proper persons’ requirements; 7.3.2.7 the Staff Friends and Family Test; and 7.3.2.8 flu vaccinations and other national vaccination programmes. 7.4 Risk 7.4.1 The Committee will monitor risks identified in the Trust’s Board Assurance Framework that have been allocated for oversight by the Committee. 7.4.2 The Committee will establish and maintain an overview of the Trust’s people risks and ensure the effectiveness and implementation of controls for people risks and actions to mitigate these risks. Page 4 of 8 7.4.3 The Committee will refer any potential risks to patient safety or quality identified by the Committee to the Quality Committee. 7.4.4 The Committee will commission and oversee assurance deep dives into specific identified risks at the request of either the Committee Chair or the chair of the Board. 7.5 CQC Quality Statements 7.5.1 The Committee will also receive assurance on the organisation’s compliance against the refreshed CQC quality statements that relate to culture, including equality diversity and inclusion. 7.6 Reporting 7.6.1 The Committee will advise the Trust Board on the appropriate key performance indicators, measures and benchmarks in the three areas of culture, capacity and capability and skills. 7.6.2 The Committee will ensure robust supporting data quality for any key performance indicators, measures and benchmarks within the areas of culture, capacity and capability and skills. 7.6.3 The Committee will review any submissions to national bodies before these are presented to the Board for approval. 8. Accountability and Reporting 8.1 The Chair of the Committee will report to the Board following each meeting, drawing the Board’s attention to any matters of significance or where actions or improvements are needed. 8.2 The Committee will report to the Audit and Risk Committee at least annually on its work in support of the annual governance statement, specifically commenting on the staff report and the appropriateness of the self-assessment of the effectiveness of the system of internal control and the disclosure of any significant internal control issues in the annual governance statement. 8.3 Appendix A sets out the sub-committees that report to and support the Committee in fulfilling its duties and responsibilities. The Committee will receive the minutes of those meetings and at least an Annual Report of their work. 9. Review of Terms of Reference and Performance and Effectiveness 9.1 At least once a year the Committee will review its collective performance and its terms of reference. Any proposed changes to the terms of reference will be recommended to the Board for approval. Page 5 of 8 10. References 10.1 Employment Rights Act 1996 10.2 Equality Act 2010 10.3 Public Interest Disclosure Act 1998 10.4 Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 10.5 NHS Constitution 10.6 Terms and conditions of service for doctors and dentists in training (England) 2016 - December 2019 Page 6 of 8 Appendix A Board of Directors Audit and Risk Committee Finance and Investment Committee People and Organisational Development Committee Quality Committee Equality, Diversity and Inclusion Steering Group People Board Staff Partnership Forum Violence and Aggression Steering Group Page 7 of 8 Remuneration and Appointment Committee People and Organisational Development Committee Terms of Reference Version: 7 Document Monitoring Information Approval Committee: Board of Directors Date of Approval: 9 September 2025 Responsible Committee: People and Organisational Committee Monitoring (Section 9) for Completion and Presentation to Approval Committee: Target audience: Key words: Main areas affected: Summary of most recent changes if applicable: Consultation: Number of pages: Type of document: Does this document replace or revise an existing document? Should this document be made available on the public website? Is this document to be published in any other format? September 2026 Board of Directors, People and Organisational Development Committee, Staff People, OD, Committee, Board, Terms of Reference Trust-wide Removal of Charitable Funds Committee, now defunct, from Appendix A Chief People Officer 8 Committee Terms of Reference Yes Yes No Page 8 of 8
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/People-and-OD-Committee-ToR-September-2025.pdf

Having an endobronchial ultrasound (EBUS) - patient information

Description
This factsheet explains what an endobronchial ultrasound (EBUS) is and what it involves so that you know what to expect.
Url
/Media/UHS-website-2019/Patientinformation/Endoscopy/Having-an-endobronchial-ultrasound-EBUS-1735-PIL.pdf

Your child's medication: Venlafaxine for cataplexy - patient information

Description
This factsheet explains how your child should take venlafaxine as part of their treatment programme for narcolepsy with cataplexy.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-medication-Venlafaxine-for-cataplexy-3550-PIL.pdf

Your child's diabetes annual review - patient information

Description
This factsheet explains what will happen at your child's diabetes annual review appointment so you know what to expect and can help to prepare your child.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-diabetes-annual-review-3077-PIL.pdf
471 to 480 of 690
Previous … 46 47 48 49 50 … Next